Noémi Dénes Selected Research

Radiopharmaceuticals

1/2021	In Vivo Molecular Imaging of the Efficacy of Aminopeptidase N (APN/CD13) Receptor Inhibitor Treatment on Experimental Tumors Using 68Ga-NODAGA-c(NGR) Peptide.
11/2020	In vivo assessment of aminopeptidase N (APN/CD13) specificity of different 68Ga-labelled NGR derivatives using PET/MRI imaging.
1/2020	In Vivo Imaging of Hypoxia and Neoangiogenesis in Experimental Syngeneic Hepatocellular Carcinoma Tumor Model Using Positron Emission Tomography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noémi Dénes Research Topics

Disease

10	Neoplasms (Cancer) 04/2023 - 01/2017
4	Melanoma (Melanoma, Malignant) 01/2021 - 01/2017
2	Carcinogenesis 05/2024 - 04/2023
2	Hypoxia (Hypoxemia) 04/2024 - 01/2020
2	Reperfusion Injury 04/2024 - 03/2022
1	Peripheral Arterial Disease 04/2024
1	Prostatic Neoplasms (Prostate Cancer) 09/2022
1	Ischemia 03/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2022
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Experimental Melanoma 01/2017

Drug/Important Bio-Agent (IBA)

6	CD13 Antigens (Alanine Aminopeptidase)IBA 04/2024 - 01/2020
3	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 04/2023 - 01/2020
3	68Ga-NOTA-c(NGR)IBA 03/2022 - 01/2020
3	RadiopharmaceuticalsIBA 01/2021 - 01/2020
3	Melanins (Melanin)IBA 08/2017 - 01/2017
2	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 04/2024 - 11/2020
2	asparagine-glycine-arginineIBA 12/2021 - 11/2020
2	Peptides (Polypeptides)IBA 08/2021 - 01/2021
1	Capsules (Microcapsules)IBA 05/2024
1	Glucose (Dextrose)FDA LinkGeneric 04/2024
1	Gallium-68IBA 04/2023
1	BismuthIBA 04/2023
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2023
1	Chelating AgentsIBA 04/2023
1	CyclodextrinsIBA 04/2023
1	Dinoprostone (PGE2)FDA Link 04/2023
1	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 04/2023
1	BombesinIBA 09/2022
1	Bombesin Receptors (Bombesin Receptor)IBA 09/2022
1	AcidsIBA 09/2022
1	Scandium-44IBA 09/2022
1	NGR peptideIBA 12/2021
1	actinoninIBA 01/2021
1	ubenimexIBA 01/2021
1	polypeptide CIBA 11/2020
1	IntegrinsIBA 01/2020
1	acetyl0Nle(4)-Asp(5)-Phe(7)- alpha-MSH (4-11)IBA 08/2017
1	Melanocyte-Stimulating Hormones (MSH)IBA 08/2017
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 08/2017
1	Type 1 Melanocortin ReceptorIBA 08/2017
1	alpha-MSHIBA 08/2017
1	Radioisotopes (Radionuclides)IBA 05/2017
1	Procainamide (Procan)FDA LinkGeneric 05/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017

Therapy/Procedure

4	Intravenous Injections 11/2020 - 01/2017
2	Therapeutics 01/2021 - 11/2020
2	Subcutaneous Injections 11/2020 - 05/2017
1	Transplantation 05/2024
1	Tourniquets 04/2024
1	Ligation 03/2022